Australian Capital Territory
Drugs of Dependence Regulations
Subordinate Law No. 14 of 19931

The Australian Capital Territory Executive, in accordance with section 5 of the Subordinate Laws Act 1989, makes the following Regulations under the Drugs of Dependence Act 1989.
Dated 26 March 1993.
WAYNE BERRY
Minister
BILL WOOD
Minister

Citation
1.  These Regulations may be cited as the Drugs of Dependence Regulations.
Commencement
2.  (1)  Regulations 1, 2 and 3 commence on the day on which these Regulations are notified in the Gazette.
(2)  The remaining provisions commence on the day on which section 4 of the Drugs of Dependence (Amendment) Act (No. 2) 1993 commences.
Interpretation
3.  In these Regulations—
“Act” means the Drugs of Dependence Act 1989.
Drugs of dependence
4.  For the purposes of the definition of “drug of dependence” in section 4 of the Act, the substances specified in Schedule 3 are prescribed.
Commercial quantities
5.  For the purposes of the definition  of “commercial quantity” in subsection 160 (1) of the Act—
	(a)	the prescribed quantity of a drug of dependence specified in column 1 of Schedule 1 is the quantity specified in the appropriate column or columns of Schedule 1 opposite the reference to that drug; and
	(b)	the prescribed quantity of a prohibited substance specified in column 1 of Schedule 2 is the quantity specified in the appropriate column or columns of Schedule 2 opposite the reference to that substance.
Traffickable quantities
6.  For the purposes of the definition  of “traffickable quantity” in subsection 160 (1) of the Act—
	(a)	the prescribed quantity of a drug of dependence specified in column 1 of Schedule 1 is the quantity specified in the appropriate column or columns of Schedule 1 opposite the reference to that drug; and
	(b)	the prescribed quantity of a prohibited substance specified in column 1 of Schedule 2 is the quantity specified in the appropriate column or columns of Schedule 2 opposite the reference to that substance.

	schedule 1	Regulations  5 and 6
Drugs of Dependence—General
Column 1	Column 2	Column 3	

Drug	Traffickable quantity (grams)	Commercial quantity (kilograms)	
Acetyldihydrocodeine, except when compounded with 1 or more other medicaments—
(a)	in divided preparations containing not more than 100 mg of acetyldihydrocodeine per dosage unit; or
(b)	in undivided preparations with a concentration of not more than 2.5% of acetyldihydrocodeine 		2.00	2.00
Acetylmethadol		2.00	2.00
Acetylmorphines		2.00	2.00
Alfentanil		0.005	0.005
Allylprodine		2.00	2.00
Alphacetylmethadol		10.00	10.00
Alphameprodine		0.20	0.20
Alphamethadol 		0.20	0.20
Alphaprodine		25.00	25.00
Amphetamine		2.00	2.00
Amylobarbitone, except when packed and labelled
for injection		20.00	20.00
Anileridine		25.00	25.00
Benzethidine		10.00	10.00
Benzylmorphine		5.00	5.00
Betacetylmethadol		5.00	5.00
Betameprodine		5.00	5.00
Betamethadol		5.00	5.00
Betaprodine		5.00	5.00
Bezitramide		5.00	5.00
Buprenorphine		0.05	0.05
Butobarbitone		20.00	20.00
Butorphanol		2.00	2.00
Carfentanyl		0.005	0.005
Clonitazene		5.00	5.00
Cocaine		2.00	2.00
Coca Leaf		250.00	80.00
Codeine, except when compounded with 1 or more
other medicaments—
(a)	in divided preparations containing 30 mg or less
of codeine per dosage unit; or
(b)	in undivided preparations containing 1% or less
of codeine		10.00	10.00
Codeine-N-oxide		10.00	10.00
Codoxime		10.00	10.00
Concentrate of Poppy Straw (the material arising when
poppy straw has entered into a process for concentration
of its alkaloids)		250.00	250.00
4-Cyano-2-dimethylamino-4,4-diphenylbutane
(Methadone intermediate)		2.00	2.00
4-Cyano-1-methyl-4-phenylpiperidine (Pethidine
intermediate A)		10.00	10.00
Cyclobarbitone		20.00	20.00
Dexamphetamine		2.00	2.00
Dextromoramide		2.00	2.00
Dextropropoxyphene, except when—
(a)	in divided preparations containing 135 mg or 
less of dextropropoxyphene per dosage unit; or
(b)	in liquid preparations containing 2.5% or less
of dextropropoxyphene		27.00	27.00
Diampromide		5.00	5.00
Diethylthiambutene		5.00	5.00
Difenoxin, except in preparations containing, per dosage unit, 0.5 mg or less of difenoxin and a quantity of atropine sulphate equivalent to at least 5% of the dose of difenoxin 	2.00	2.00
Dihydrocodeine, except when compounded with 1 or more other medicaments—
(a)	in divided preparations containing not more than 100 mg of dihydrocodeine per dosage unit; or
(b)	in undivided preparations with a concentration of not more than 2.5% of dihydrocodeine		10.00	10.00
Dihydromorphine		10.00	10.00
Dimenoxadol 		10.00	10.00
Dimepheptanol 		10.00	10.00
Dimethylthiambutene		20.00	20.00
Dioxaphetyl Butyrate		2.00	2.00
Diphenoxylate, except in preparations containing, per dosage unit, 2.5 mg or less of diphenoxylate and a quantity of atropine sulphate equivalent to at least 1% of the dose of diphenoxylate		2.00	2.00
Dipipanone		10.00	10.00
Drotebanol		2.00	2.00
Ecgonine		10.00	10.00
Ethylamphetamine		2.00	2.00
Ethylmethylthiambutene		10.00	10.00
Ethylmorphine, except when compounded with 1 or more other medicaments—
(a)	in divided preparations containing not more than 100 mg of ethylmorphine per dosage unit; or
(b)	in undivided preparations with a concentration of not more than 2.5% of ethylmorphine		2.00	2.00
Etonitazene		5.00	5.00
Etoxeridine		5.00	5.00
Fenetylline		2.00	2.00
Fentanyl		0.005	0.005
Furethidine		1.00	1.00
Hydrocodone		2.00	2.00
Hydromorphinol		2.00	2.00
Hydromorphone		2.00	2.00
Hydroxypethidine		5.00	5.00
Isomethadone		2.00	2.00
Levamphetamine		2.00	2.00
Levomethamphetamine		2.00	2.00
Levomethorphan		2.00	2.00
Levomoramide		2.00	2.00
Levophenacylmorphan		2.00	2.00
Levorphanol		1.00	1.00
Mecloqualone		60.00	60.00
Metazocine		7.00	7.00
Methadone		2.00	2.00
Methamphetamine		2.00	2.00
Methyldesorphine		2.00	2.00
Methyldihydromorphine		2.00	2.00
2-Methyl-3-morpholino-1,1-diphenylpropane
Carboxylic Acid (Moramide intermediate)		8.00	8.00
Methylphenidate 		2.00	2.00
1-Methyl-4-phenylpiperidine-4-carboxylic Acid
(Pethidine intermediate C)		10.00	10.00
Metopon		2.00	2.00
Morpheridine		2.00	2.00
Morphine		2.00	1.50
Morphine Methobromide		2.00	1.00
Morphine-N-oxide		2.00	2.00
Myrophine		20.00	20.00
Nabilone		0.40	0.40
Nicocodine, except when compounded with 1 or more
other medicaments—
(a)	in divided preparations containing not more than 100 mg of nicocodine per dosage unit; or
(b)	in undivided preparations with a concentration of not more than 2.5% of nicocodine 		2.00	2.00
Nicodicodine, except when compounded with 1 or more other medicaments—
(a)	in divided preparations containing not more than 100 mg of nicodicodine per dosage unit; or
(b)	in undivided preparations with a concentration of not more than 2.5% of nicodicodine 		2.00	2.00
Nicomorphine		2.00	2.00
Noracymethadol 		2.00	2.00
Norcodeine, except when compounded with 1 or more other medicaments—
(a)	in divided preparations containing not more than 100 mg of norcodeine per dosage unit; or
(b)	in undivided preparations with a concentration of not more than 2.5% of norcodeine 		2.00	2.00
Norlevorphanol 		2.00	2.00
Normethadone		5.00	5.00
Normorphine		20.00	20.00
Norpipanone		10.00	10.00
Opium in any form, except the alkaloids noscapine and  papaverine		20.00	20.00
Oxycodone		5.00	5.00
Oxymorphone		2.00	2.00
Pentazocine		20.00	20.00
Pentobarbitone, except when packed and labelled for
injection		20.00	20.00
Pethidine		10.00	10.00
Phenadoxone		10.00	10.00
Phenampromide		10.00	10.00
Phenazocine		1.00	1.00
Phendimetrazine		5.00	5.00
Phenmetrazine		5.00	5.00
Phenomorphan		5.00	5.00
Phenoperidine		1.00	1.00
4-Phenylpiperidine-4-carboxylic Acid Ethyl Ester
(Pethidine intermediate B)		10.00	10.00
Pholcodine, except when compounded with 1 or more other medicaments—
(a)	in divided preparations containing not more than 100 mg of pholcodine per dosage unit; or
(b)	in undivided preparations with a concentration of not more than 2.5% of pholcodine 		5.00	5.00
Piminodine		10.00	10.00
Piritramide		1.00	1.00
Proheptazine		1.00	1.00
Properidine		25.00	25.00
Propiram		10.00	10.00
Quinalbarbitone		20.00	20.00
Racemethorphan		2.00	2.00
Racemoramide		2.00	2.00
Racemorphan		2.00	2.00
Secbutobarbitone		20.00	20.00
Sufentanil		0.005	0.005
Thebacon		2.00	2.00
Thebaine		2.00	2.00
Tilidine		20.00	20.00
Trimeperidine		10.00	10.00
A substance which is, in relation to a drug of dependence specified elsewhere in this Schedule—
(a)    an active principle of that drug;
(b)    a preparation or admixture of that drug; or
(c)    a salt of that drug or active principle;
except where the substance is separately specified in
this Schedule		The minimum traffickable quantity
and the minimum commercial quantity, respectively, of—
(a)	the drug of dependence in relation to which the substance is specified in this item; or
(b)	if there is more than 1 such drug—the drug referred to in paragraph (a) in relation to which the minimum traffickable quantity and the minimum commercial quantity are respectively the least.

	Schedule 2	Regulations 5 and 6
PROHIBITED SUBSTANCES
Column 1	Column 2	Column 3	

Substance	Traffickable quantity (grams)	Commercial quantity (kilograms)	
Acetorphine		2.00	2.00
Acetyl-a-methylfentanyl		0.005	0.005
Alkoxyamphetamines and bromo-substituted alkoxyamphetamines, except where separately specified in this Schedule		0.50	0.50
Alkoxyphenethylamines and alkyl-substituted alkoxyphenethylamines, except where separately specified in this Schedule		0.50	0.50
2-Amino-1-(2,5-dimethoxy-4-methyl) phenylpropane (STP, DOM)		0.50	0.50
4-Bromo-3,5-dimethoxyamphetamine		0.50	0.50
4-Bromo-2,5-dimethoxyphenethylamine (BDMPEA)		0.50	0.50
3-Bromo-4-methoxyamphetamine		0.50	0.50
4-Bromo-3-methoxyamphetamine		0.50	0.50
Bufotenine		2.00	2.00
Cannabis		100.00	100.00
Cannabis Oil		2.00	2.00
Cannabis Resin 		20.00	50.00
Cathinone		2.00	2.00
Desomorphine		2.00	2.00
N,N-Diethyltryptamine (DET)		2.00	2.00
2,4-Dimethoxyamphetamine		0.50	0.50
3,4-Dimethoxyamphetamine		0.50	0.50
2,5-Dimethoxy-4-bromoamphetamine (DOB)		0.50	0.50
3,4-Dimethoxy-5-ethoxyamphetamine		0.50	0.50
2,5-Dimethoxy-4-ethoxyamphetamine		0.50	0.50
4,5-Dimethoxy-2-ethoxyamphetamine		0.50	0.50
2,5-Dimethoxy-4-ethyl-a-methylphenylethylamine
(DOET)		0.50	0.50
2,3-Dimethoxy-4,5-methylenedioxyamphetamine		0.50	0.50
2,5-Dimethoxy-3,4-methylenedioxyamphetamine		0.50	0.50
2,5-Dimethoxy-a-methylphenylethylamine (DMA)		0.50	0.50
3,4-Dimethoxyphenylethylamine		0.50	0.50
3-(2-Dimethylaminoethyl)-4-hydroxyindole 
(Psilocine, Psilotsin)		2.00	2.00
3-(1,2-Dimethylheptyl)-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran (DMHP)		2.00	2.00
N,N,-Dimethyltryptamine (DMT)		2.00	2.00
4,5-Ethylenedioxy-3-methoxyamphetamine		0.50	0.50
Eticyclidine (PCE)		2.00	2.00
Etorphine		5.00	2.00
Harmaline		2.00	2.00
Harmine		2.00	2.00
Heroin		2.00	1.50
3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl- 6H-dibenzo[b,d]pyran (Parahexyl)		2.00	2.00
b-Hydroxyfentanyl		0.005	0.005
b-Hydroxy-3-methylfentanyl 		0.005	0.005
Ketobemidone		2.00	2.00
Lysergic Acid		0.002	0.002
Lysergide (LSD, LSD-25)		0.002	0.002
Mescaline-see 3,4,5-Trimethoxyphenethylamine 
Methaqualone		50.00	50.00
2-Methoxy-3, 4-methylenedioxyamphetamine		50.00	50.00
2-Methoxy-4, 5-methylenedioxyamphetamine		0.50	0.50
4-Methoxy-2, 3-methylenedioxyamphetamine		0.50	0.50
5-Methoxy-3, 4-methylenedioxy-a-methylphenylethylamine (MMDA)		0.50	0.50
2-Methoxy-3, 4-methylenedioxyphenylethylamine		0.50	0.50
3-Methoxy-4, 5-methylenedioxyphenylethylamine		0.50	0.50
4-Methoxy-a-methylphenylethylamine (PMA)		0.50	0.50
4-Methoxyphenylethylamine		0.50	0.50
4-Methylaminorex		2.00	2.00
3, 4-Methylenedioxyamphetamine (MDA)		0.50	0.50
3, 4-Methylenedioxy-N, a-dimethylphenylethylamine (MDMA)		0.50	0.50
3, 4-Methylenedioxy-N-ethylamphetamine (MDE)		0.50	0.50
3-Methylfentanyl		0.005	0.005
a-Methylfentanyl 		0.005	0.005
1-Methyl-4-phenyl-4-piperidinol propionate (MPPP)		2.00	2.00
3-Methylthiofentanyl		0.005	0.005
a-Methylthiofentanyl		0.005	0.005
Muscimol		2.00	2.00
Para-fluorofentanyl		0.005	0.005
Phencyclidine (PCP)		2.00	2.00
1-Phenylethyl-4-phenyl-4-piperidinol acetate (PEPAP)		2.00	2.00
Psilocine—see 3-(2-Dimethylaminoethyl)-4-hydroxyindole
Psilocybine		2.00	2.00
Psilotsin—see 3-(2-Dimethylaminoethyl)-4-hydroxyindole
Rolicyclidine (PHP, PCPY)		2.00	2.00
Tenocyclidine (TCP)		2.00	2.00
Tetrahydrocannabinols (THC) and their alkyl homologues, except where separately specified in this Schedule		2.00	5.00
2, 3, 4, 5-Tetramethoxyamphetamine		0.50	0.50
Thiofentanyl		0.005	0.005
2, 3, 4-Trimethoxyamphetamine		0.50	0.50
2, 3, 5-Trimethoxyamphetamine		0.50	0.50
2, 3, 6-Trimethoxyamphetamine		0.50	0.50
2, 4, 5-Trimethoxyamphetamine		0.50	0.50
2, 4, 6-Trimethoxyamphetamine		0.50	0.50
3, 4, 5-Trimethoxy-a-methylphenylethylamine (TMA)		0.50	0.50
3, 4, 5-Trimethoxyphenethylamine (mescaline) and other substances structurally derived from methoxy-phenylethylamine, except—
(a)	methoxyphenamine; or
(b)	where separately specified in this Schedule		7.50	7.50
1-(3, 4, 5-Trimethoxyphenyl)-2-aminobutane		0.50	0.50
2, 4, 5-Trimethoxyphenylethylamine		0.50	0.50
A substance which is, in relation to a prohibited substance specified elsewhere in this Schedule—
(a)	an active principle of that prohibited substance;
(b)	a preparation or admixture of that prohibited substance; or
(c)	a salt of that prohibited substance or active principle;
except where the first-mentioned substance is separately specified in this Schedule		The minimum traffickable quantity
and the minimum commercial quantity, respectively, of—
(a)	the prohibited substance in relation to which the substance is specified in this item; or
(b)	if there is more than 1 such prohibited substance—the prohibited substance referred to in paragraph (a) in relation to which the minimum traffickable quantity and the minimum commercial quantity are respectively the least.
A substance (“drug analogue”) which is, in relation to another substance (being a drug of dependence or a substance specified elsewhere in this Schedule, or a stereoisomer, a structural isomer (with the same constituent groups) or an alkaloid of such a drug or substance)—
(a)	a stereoisomer;
(b)	a structural isomer having the same constituent groups;
(c)	an alkaloid;
(d)	a structural modification notionally obtained in 1 or more of the following ways:
	(i)	by the replacement of up to 2 carbocyclic or heterocyclic ring structures with different carbocyclic or heterocyclic ring structures;
	(ii)	by the addition of hydrogen atoms to 1 or more unsaturated bonds;
	(iii)	by the addition of 1 or more of the following groups, namely alkoxy, cyclic diether, acyl, acyloxy, mono-amino and dialkylamino groups with up to 6 carbon atoms in any alkyl residue; alkyl, alkenyl and alkynyl groups with up to 6 carbon atoms in the group, where the group is attached to oxygen (for example, an ester or an ether group), nitrogen, sulphur or carbon; and halogen, hydroxy, nitro and amino groups;
	(iv)	by the replacement of 1 or more of the groups specified in subparagraph (iii) with another such group or groups;
	(v)	by the conversion of a carboxyl or an ester group into an amide group; or
(e)	otherwise an homologue, analogue, chemical derivative or substance substantially similar in chemical structure;
however manufactured or actually obtained, except where the drug analogue—
(f)	is a drug of dependence;
(g)	is separately specified in this Schedule;
(h)	is specified in a Schedule to the Poisons and Drugs Act 1978; or
(i)	is specified in the Schedule to the Public Health (Prohibited Drugs) Act 1957		The minimum traffickable quantity
and the minimum commercial quantity, respectively, of—
(a)	the drug of dependence or prohibited substance in relation to which the substance is a drug analogue; or
(b)	if there is more than 1 such drug or prohibited substance—the drug or prohibited substance referred to in paragraph (a) in relation to which the minimum traffickable quantity and the minimum commercial quantity are respectively the least.

	Schedule 3	Regulation 4
DRUGS OF DEPENDENCE—MANUFACTURING
Acetylmorphines
Amphetamine
Amylobarbitone
Butobarbitone
Cyclobarbitone
Dexamphetamine
Mecloqualone
Methamphetamine
Methylphenidate
Nabilone
Pentazocine
Pentobarbitone
Phencyclidine
Phenmetrazine
Quinalbarbitone
Secbutobarbitone
A substance which is, in relation to a drug of dependence specified elsewhere in this Schedule—
(a)	an active principle of that drug;
(b)	a preparation or admixture of that drug; or
(c)	a salt of that drug or active principle

NOTE
1.	Notified in the ACT Gazette on 31 March 1993.

©  Australian Capital Territory 1993